Category Archives: Congenital disorders
Congenital disorders
Assessing sugar-sweetened beverage consumption in early pregnancy using a substance abuse framework
Nov
Abstract Sugar-sweetened beverages (SSB) are previously reported to jeopardize maternal fetal health, most well-known for gestational diabetes, childhood obesity, and cognitive impairment. Although warnings and diet recommendations urge pregnant women to consume less SSB, there is no noticeable difference in their behavior. How and why reproductive women change their SSB consumption patterns were not investigated […]
Congenital disorders
Glycomine Presents at ASHG 2023 Data from Ongoing Natural History Study with Insight into Genetic Mutations and Biomarkers for PMM2-CDG
Nov
#inform-video-player-1 .inform-embed { margin-top: 10px; margin-bottom: 20px; } #inform-video-player-2 .inform-embed { margin-top: 10px; margin-bottom: 20px; } SAN CARLOS, Calif.–(BUSINESS WIRE)–Nov 2, 2023– Glycomine, Inc., a biotechnology company focused on developing new therapies for orphan diseases, announced the presentation of summary findings from its ongoing natural history study at the American Society for Human Genetics (ASHG) […]
The global pacemakers market size was US$ 3.9 billion in 2021. The global pacemakers market is forecast to grow to US$ 5.9 billion by 2030 by registering a compound annual growth rate (CAGR) of 5.1% during the forecast period from 2022 to 2030. Request To Download Free Sample of This Strategic Report @https://reportocean.com/industry-verticals/sample-request?report_id=Pol1267 A pacemaker […]
A new study has highlighted a lack of clinical research to address the leading causes of severe sight impairment (SSI) among the working-age UK population, which costs the UK economy an estimated £7.4bn annually. The study, carried out by researchers from Anglia Ruskin University and the University of Oxford, examined how clinical studies align with […]
EL PASO, Texas (KFOX14/CBS4) — A tag-team event featuring some of El Paso’s biggest names in the world of Lucha Libre are preparing to lay the smackdown on youth heart disease. Wrestling icon Cinta de Oro, together with The Manor at Ten Eleven and Lucha League Wrestling of El Paso will host Lucha Libre Por […]
Next month, the Food and Drug Administration will decide on the regulatory approval of two gene therapies for sickle cell disease. Exa-cel and lovo-cel are potentially one-time treatment options for a patient population that has long experienced unmet need. The two treatments—exa-cel (exagamglogene autotemcel) and lovo-cel (lovotibeglogene autotemcel)—attack SCD at its genetic root. In the […]
EvokAI Creative Labs’ Movement Disorder Monitor (MDM) Flex Sensor — which uses artificial intelligence (AI) in monitoring abnormal body movements — has received CE Mark approval in Europe for the management of Parkinson’s disease and other movement disorders. CE Mark approval indicates that the sensor has been assessed by the European Commission, the European Union’s […]
Anglia Ruskin University A new study has highlighted a lack of clinical research to address the leading causes of severe sight impairment (SSI) among the working-age UK population, which costs the UK economy an estimated £7.4bn annually. The study, carried out by researchers from Anglia Ruskin University and the University of Oxford, examined how clinical […]